March 8, 2017 / 6:48 AM / 7 months ago

BRIEF-Unichem Labs gets FDA nod for migraine drug

March 8 (Reuters) - Unichem Laboratories Ltd

* Says receives ANDA approval from USFDA for rizatriptan benzoate odt & rizatriptan benzoate tablets USP

* Says product will be commercialized from Unichem’s Goa plant

* Says active pharmaceutical ingredient will also be made in house at Roha API plant

* Says drug indicated for the acute treatment of migraine in adults and in pediatric patients 6 to 17 years of age Source text: bit.ly/2mWit4t Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below